A comparison of echocardiographic findings in young adults with cardiomyopathy: With and without a history of methamphetamine abuse

Clinical Cardiology

Volumn 32, Issue 6, 2009, Pages

  Ito, Hiroki ^a,b   Yeo, Khung Keong ^a,c   Wijetunga, Mevan ^d   Seto, Todd B ^a,e   Tay, Kevin ^a   Schatz, Irwin J ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d U of MN St Cloud Hospital FMR   (United States)

^e QUEEN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG DEPENDENCE; FEMALE; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE SIZE; HEART VOLUME; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PREVALENCE; RETROSPECTIVE STUDY; TOXICOLOGY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; URINALYSIS;

ADULT; AMPHETAMINE-RELATED DISORDERS; CARDIOMYOPATHY, DILATED; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HEART ATRIA; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; METHAMPHETAMINE; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 67650458709     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20367     Document Type: Article

References (20)

1. National Institute of Drug Abuse. Research Report Series: Methamphetamine Abuse and Addiction. Bethesda, MD: National Institutes of Health; 2002. NIH publication No. 02-4210.
2. U.S. Drug Enforcement Administration. Methamphetamine. Available at: http://www.usdoj.gov/dea/concern/meth.html. Accessed February 16, 2007.
3. Lineberry TW, Bostwick JM. Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc. 2006;81:77-84. (Pubitemid 43054321)
4. Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: National Findings, September 2005.
5. Albertson T, Derlet RW, Van Hoozen BE. Methamphetamine and the expanding complications of amphetamines. West J Med. 1999;170:214-219.
6. Beebe D, Walley E. Smokable methamphetamine ("Ice"): an old drug in a different form. Am Family Physician. 1995;51:449-453.
7. Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA. 1991;265: 1152-1154.
8. Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamine- associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol. 2003;41:981-986. (Pubitemid 38018490)
9. Yeo KK, Wijetunga M, Ito H, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med. 2007;120:165-171. (Pubitemid 46175764)
10. Members of the Chamber Quantification Writing Group. Recommendations for Chamber Quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
11. Rossi A, Cicoria M, Zanolla L, et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:1425. (Pubitemid 35192867)
12. Dini FL, Cortigiani L, Baldini U, et al. Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. Am J Cardiol. 2002;89:518-523. (Pubitemid 34178560)
13. Sun JP, James KB, Yang XS, et al. Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated vs nondilated right ventricular cavities. Am J Cardiol. 1997;80:1583-1587. (Pubitemid 28011835)
14. Jacobs LJ. Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol. 1989;12:725-727. (Pubitemid 20025699)
15. Islam MN, Kuroki H, Hongcheng B, et al. Cardiac lesions and their reversibility after long term administration of methamphetamine. Foren Sci Int. 1995;75:29-43.
16. He SY, Matoba R, Fujitani N, Sodesaki K, Onishi S. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol. 1996;17: 155-162. (Pubitemid 26149147)
17. Henning RJ, Cuevas J. Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte hypertrophy. J Cardiovasc Pharmacol. 2006;48:802-813. (Pubitemid 44276457)
18. Logan BK, Fligner CL, Haddix T. Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci. 1998;43:28-34. (Pubitemid 28063701)
19. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci. 1999;44:359-368. (Pubitemid 29131848)
20. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450-458. (Pubitemid 16119719)